問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Linkou Chang Gung Medical Foundation
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2023-06-02 - 2030-12-30
Condition/Disease
Multiple Myeloma
Test Drug
Iberdomide (CC-220)Revlimid (Lenalidomide) Capsules
Participate Sites6Sites
Recruiting6Sites
2025-04-01 - 2027-12-31
Participate Sites4Sites
Recruiting4Sites
2025-07-15 - 2029-11-13
2025-08-01 - 2032-03-02
Non-small Cell Lung Cancer
tablet
Participate Sites5Sites
Recruiting5Sites
2024-03-01 - 2030-07-16
Participate Sites10Sites
Recruiting10Sites
2020-12-15 - 2026-01-30
2019-11-30 - 2026-09-30
xxxxxx
Participate Sites9Sites
Recruiting9Sites
2023-10-13 - 2029-12-31
2022-08-01 - 2027-12-31
Participate Sites8Sites
Recruiting8Sites
2025-06-01 - 2034-08-15
全部
